title: Dabigatran: uncharted waters and potential harms.
authors: Department of Emergency Medicine, University of Texas Health Science Center at Houston, 6431 Fannin Street, JJL 450, Houston, TX 77030, USA. Ryan.P.Radecki@uth.tmc.edu
authors: Ryan P
authors: RP
authors: Radecki
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects; D001562:Benzimidazoles / Q000009:adverse effects*; D017326:Clinical Trials, Phase III as Topic; D000069604:Dabigatran; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D060735:Pharmacovigilance; D016032:Randomized Controlled Trials as Topic; D013917:Thrombin / Q000037:antagonists & inhibitors*; D013923:Thromboembolism / Q000139:chemically induced; D014859:Warfarin / Q000009:adverse effects; D015091:beta-Alanine / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D015091:beta-Alanine; D014859:Warfarin; D013917:Thrombin; D000069604:Dabigatran